home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Next-Gen Kinase Inhibitors

 
  February 01, 2013  
     
 
The Revere Hotel, 200 Stuart Street
June 17-19, 2013


This established and well recognized kinase conference addresses re-occurring questions about selectivity, safety, resistance and novelty.  After many years of research and therapeutic developments of kinase inhibitors, the field still offers new opportunities as novel kinases and their inhibitors are making an appearance. In addition, interest in the repurposing of already developed drugs is growing immensely.

This conference addresses questions such as what lies ahead, what is in store for the pharmaceutical industry and what new avenues are opening up in regards to technologies and methods used or in regards to novel targets and therapeutic approaches explored.  Take advantage of the opportunity to present your data, concepts and results as part of a highly knowledgeable speaker faculty by submitting a speaking proposal for this event.
 
Click here for more information. 
 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: For speaker information, please visit our website.
 
Deadline for Abstracts: May 10, 2013
 
Registration: Register Now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.